{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OPT.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPT.AU\",,,,,undefined,":{"symbol":"OPT.AU","market":"AU","secType":"STK","nameCN":"OPTHEA LTD","latestPrice":0.6,"timestamp":1744870320000,"preClose":0.6,"halted":3,"volume":0,"delay":0,"nameEN":"OPTHEA LTD","floatShares":786007538,"shares":1231287336,"eps":-0.4100844657773345,"marketStatus":"Halted","change":0,"latestTime":"04-17 16:12:00 AEST","open":0.6,"high":0.6,"low":0.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.4100844657773345,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.6,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPT.AU\",,,,,undefined,":{"symbol":"OPT.AU","floatShares":786007538,"roa":"-73.34%","roe":"-3383.08%","lyrEps":-0.537815,"shares":1231287336,"dividePrice":0,"high":0.6,"amplitude":0,"preClose":0.6,"low":0.6,"week52Low":0.335,"pbRate":"-2.81","psRate":"2269.69","week52High":1.165,"institutionHeld":0,"latestPrice":0.6,"eps":-0.4100940521923434,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.4100940521923434,"open":0.6,"prevYearClose":0.81,"prevWeekClose":0.6,"prevMonthClose":0.6,"prevQuarterClose":0.6,"fiveDayClose":0.6,"twentyDayClose":0.6,"sixtyDayClose":0.905},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OPT.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.007524}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OPT.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526524680","title":"Hearts and Minds Investments Portfolio Falls Nearly 9% in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2526524680","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526524680?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:19","pubTimestamp":1744330743,"startTime":"0","endTime":"0","summary":"Hearts and Minds Investments'  portfolio declined 8.9% in March, bigger than the MSCI World Index's 5.2% drop in the same month, according to a Friday filing with the Australian bourse.The decline occurred as equity markets faced volatility during the month amid uncertainties about US trade policies, the filing said.The investment company also saw the unsuccessful outcome of Opthea's  phase 3 clinical trials for its lead drug candidate, OPT-302. This prompted Hearts & Minds to write down its investment to zero.Before its trading suspension, Opthea represented around 2.4% of Hearts and Minds Investments' portfolio, per a Tuesday statement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPT.AU","BK7508","OPT","BK4139","BK7067","HM1.AU"],"gpt_icon":0},{"id":"2526776643","title":"Thursday’s HotCopper Trends: Sayona merger, Opthea slashes jobs | April 10, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526776643","media":"The Market Herald","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526776643?lang=en_us&edition=fundamental","pubTime":"2025-04-10 11:04","pubTimestamp":1744254240,"startTime":"0","endTime":"0","summary":"The ASX has been up, charging 4.7% higher at around 7,720 points today.Sayona Mining  has been among the most watched on HotCopper forums on news it has merged with NASDAQ-listed Piedmont Lithium. The name of the company will be changed to Elevra Lithium once the deal closes.Sayona Mining has been 1.6 cents in early afternoon trades.BOSS Energy  has also been trending on the forums after presenting at the Resources Rising Stars conference today. The company shared actual production and sales results for Q3 FY25.Finally, Opthea  shared a corporate update after the termination of its COAST Phase 3 clinical trials. In light of the negative trial results, the Board has decided to reduce costs and has slashed 65% of the workforce.Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.The material provided in this article is for information only and should not be treated as investment advice. Vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/thursdays-hotcopper-trends-sayona-merger-opthea-slashes-jobs-april-10-2025-2025-04-10/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BOE.AU","BK4139","BK7095","SYA.AU","OPT","OPT.AU","BK7067","BK7083","BK7508","BK7504"],"gpt_icon":0},{"id":"2526322798","title":"BRIEF-Opthea Says Reducing Workforce By 65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526322798","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526322798?lang=en_us&edition=fundamental","pubTime":"2025-04-10 09:31","pubTimestamp":1744248712,"startTime":"0","endTime":"0","summary":"BRIEF-Opthea Says Reducing Workforce By 65%April 10  - Opthea Ltd OPT.AX:REDUCING ITS WORKFORCE BY APPROXIMATELY 65%ONE-OFF COSTS ASSOCIATED WITH REDUCTION IN FORCE WILL BE APPROXIMATELY US$4.5MMATERIAL UNCERTAINTY ON CO'S ABILITY TO CONTINUE AS GOING CONCERNFurther company coverage: OPT.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QN1YR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OPT.AU","BK7067"],"gpt_icon":0},{"id":"2526324926","title":"Opthea Cuts 65% Staff, Terminates Drug Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2526324926","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526324926?lang=en_us&edition=fundamental","pubTime":"2025-04-10 09:16","pubTimestamp":1744247818,"startTime":"0","endTime":"0","summary":"Opthea  has terminated phase three clinical trials for two of its drug candidates following negative results, according to a Thursday Australian bourse filing.The company will be reducing its workforce by about 65% to cut costs while retaining a limited number of employees to ensure compliant termination of clinical trial activities and oversee administrative operations, the filing added.The company expects the workforce reduction to take effect from May 1 with one-off costs of about $4.5 million, resulting reduction in monthly employee costs of $1 million.The company sees unaudited cash and cash equivalents of $100 million at the end of March.The company said its ability to continue as a going concern remains materially uncertain.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","OPT.AU","OPT","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":20,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPT.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPT.AU\",market:\"AU\",,,undefined,":[]}}